Vincent Rajkumar: I’m updating my 2024 Review on myeloma for American Journal of Hematology
Vincent Rajkumar shared a post on X:
“I’m updating my 2024 Review on myeloma for American Journal of Hematology.
Just since 2022, I need to add data from:
- 9 trials in The New England Journal of Medicine (NEJM).
- 5 in Lancet journals.
- 2 in Nature Medicine and more.“
Source: Vincent Rajkumar/X
Vincent Rajkumar is a Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, and Chair for the Mayo Clinic Myeloma, Amyloidosis, and Dysproteinemia Group. He also chairs the Board of directors of The International Myeloma Foundation and the Eastern Cooperative Oncology Group (ECOG) Myeloma Committee. His extensive contributions include over 230 peer-reviewed publications, predominantly focusing on multiple myeloma and related plasma cell disorders. Furthermore, Dr. Rajkumar is a Section Editor for multiple myeloma and related disorders for Leukemia and an Associate Editor for the Mayo Clinic Proceedings.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023